What is Jazz Pharmaceuticals plc worth?
With the base-case assumptions below, a discounted cash flow model on Jazz Pharmaceuticals plc's reported free cash flow gives $558.27 per share. The share price was $237.95 on September 25, 2026, 57% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 7.5% | 10.0% | $328.71 | +38% |
| Base | 12.5% | 9.0% | $558.27 | +135% |
| Bull | 17.5% | 8.0% | $1,015.68 | +327% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $733.89 | $788.31 | $854.82 | $937.96 | $1,044.85 |
| 8.0% | $602.22 | $637.51 | $679.22 | $729.27 | $790.44 |
| 9.0% | $506.30 | $530.43 | $558.27 | $590.75 | $629.14 |
| 10.0% | $433.47 | $450.63 | $470.08 | $492.30 | $517.95 |
| 11.0% | $376.40 | $388.98 | $403.04 | $418.86 | $436.78 |
Where the presets come from
Base: years 1 to 5 grow at Jazz Pharmaceuticals plc's revenue growth rate over the last 5 fiscal years (12.5% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions